WTB
IMDZ

Washington Trust Bank’s Immune Design Corp. IMDZ Stock Holding History

Washington Trust Bank’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-500
Closed -$7K – 900
2016
Q1 		$7K Buy
500
+200
+67% +$2.31K ﹤0.01% 615
2015
Q4 		$6K Buy
300
+150
+100% +$2.58K ﹤0.01% 647
2015
Q3 		$2K Buy
150
+50
+50% +$937 ﹤0.01% 747
2015
Q2 		$2K Buy
+100
New +$2.36K ﹤0.01% 773

Other funds holding IMDZ

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Washington Trust Bank's IMDZ Position: Q2 2016 in Review

Washington Trust Bank sold out of Immune Design Corp. (IMDZ) in Q2 2016, closing a stake of 500 shares — an estimated $7K sold.

Washington Trust Bank first reported a position in IMDZ in Q2 2015 and held it in 4 quarters. The position peaked at $7K in Q1 2016. 60 funds tracked by Wall St. Rank hold IMDZ as of Q2 2016.

  • Washington Trust Bank reported no remaining Immune Design Corp. position as of Q2 2016 after selling out during the quarter.
  • Washington Trust Bank sold 500 Immune Design Corp. shares in Q2 2016, an estimated $7K.
  • Washington Trust Bank first reported a position in Immune Design Corp. in Q2 2015 and held it in 4 quarters.
  • Washington Trust Bank's Immune Design Corp. position peaked at $7K in Q1 2016.
  • 60 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2016.

Based on Washington Trust Bank's 13F filing for Q2 2016, filed 7 Jul 2016.